Skip to main content

SciNova to Develop Software for AstraZeneca India

This article has been corrected from a previous version, which stated that SciNova was developing software to determine the structure of proteins.


NEW YORK, July 21 - SciNova of Pune, India, has been tapped to develop custom software for the Bangalore, India-based AstraZeneca Research Foundation India (AZREFI), Scinova said today.


SciNova will work with researchers at AZREFI to develop software that determines the structure of small-molecule natural products based on NMR and mass spec data using a machine-learning approach.


SciNova said it would retain rights to market the product in the international market once it is developed.


AZREFI is endowed by AstraZeneca Plc, UK, and registered as a non-profit society in the state of Karnataka, India.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.